• OPEN AN ACCOUNT
Indian Indices
Sensex
78,094.64 166.49
( 0.21%)
Global Indices
Nasdaq
52,497.89 268.83
(0.51%)
Dow Jones
7,510.69 52.06
(0.70%)
Hang Seng
64,316.33 2,448.90
(3.96%)
Nikkei 225
10,879.26 -18.01
(-0.17%)
Forex
USD-INR
95.59 -0.10
(-0.11%)
EUR-INR
109.79 0.65
(0.59%)
GBP-INR
128.11 0.75
(0.59%)
JPY-INR
0.59 0.01
(1.09%)

EQUITY - MARKET SCREENER

Gallantt Ispat Ltd.
Industry :  Steel - Medium / Small
BSE Code
ISIN Demat
Book Value()
532726
INE297H01019
137.4431348
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GALLANTT
34.19
14839.98
EPS(TTM)
Face Value()
Div & Yield %
17.99
10
0.33
 

Strides Pharma Science consolidated net profit rises 54.45% in the March 2026 quarter
May 18,2026
Net profit of Strides Pharma Science rose 54.45% to Rs 126.94 crore in the quarter ended March 2026 as against Rs 82.19 crore during the previous quarter ended March 2025. Sales rose 11.18% to Rs 1323.47 crore in the quarter ended March 2026 as against Rs 1190.39 crore during the previous quarter ended March 2025.

For the full year,net profit declined 84.52% to Rs 556.19 crore in the year ended March 2026 as against Rs 3593.46 crore during the previous year ended March 2025. Sales rose 6.43% to Rs 4858.68 crore in the year ended March 2026 as against Rs 4565.34 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1323.471190.39 11 4858.684565.34 6
OPM %18.1118.30 -19.0417.58 -
PBDT207.71182.66 14 897.93614.52 46
PBT154.46133.80 15 695.53422.26 65
NP126.9482.19 54 556.193593.46 -85